Zantac Lawsuits

GSK has agreed to pay up to $2.2 billion to settle the majority of lawsuits in U.S. state courts that allege a discontinued version of the heartburn drug Zantac caused cancer. The company announced this agreement on Wednesday, stating it resolves about 80,000 cases, or 93% of the pending lawsuits against it in state courts…